pentylenetetrazole has been researched along with pd 123319 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Georgiev, VP; Kambourova, TS; Lazarova, MB | 1 |
Georgiev, V; Kambourova, T; Matsoukas, J; Pechlivanova, D; Tchekalarova, J | 1 |
Georgiev, V; Tchekalarova, J | 1 |
3 other study(ies) available for pentylenetetrazole and pd 123319
Article | Year |
---|---|
Effects of non-peptide angiotensin II-receptor antagonists on pentylenetetrazol kindling in mice.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anticonvulsants; Biphenyl Compounds; Convulsants; Drug Evaluation, Preclinical; Imidazoles; Injections, Intraventricular; Kindling, Neurologic; Losartan; Male; Mice; Pentylenetetrazole; Pyridines; Seizures; Tetrazoles | 1996 |
The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception.
Topics: Angiotensin II; Animals; Avoidance Learning; Disease Models, Animal; Drug Combinations; Imidazoles; Injections, Intraventricular; Kindling, Neurologic; Losartan; Male; Memory; Mice; Pain Measurement; Pentylenetetrazole; Pyridines; Seizures; Tail | 2003 |
Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin III; Animals; Convulsants; Desipramine; Imidazoles; Injections, Intraperitoneal; Injections, Intraventricular; Losartan; Male; Mice; Mice, Inbred ICR; Norepinephrine; Pentylenetetrazole; Pyridines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Restraint, Physical; Seizures; Stress, Psychological; Sympathetic Nervous System | 2006 |